Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells

Journal of Experimental Medicine

Volumn 205, Issue 1, 2008, Pages 19-24

  Qiu, Hong ^a   Strååt, Klas ^b   Rahbar, Afsar ^b   Wan, Min ^a   Söderberg Nauclér, Cecilia ^b   Haeggström, Jesper Z ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE B4;

ARTICLE; BIOSYNTHESIS; CYTOMEGALOVIRUS INFECTION; ENTERITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FOLDING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CYTOLOGY; ENZYME IMMUNOASSAY; FIBROBLAST; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; VIROLOGY;

ARACHIDONATE 5-LIPOXYGENASE; CELLS, CULTURED; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOTRIENE B4; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 38749132974     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20070201     Document Type: Article

References (29)

1. Mehrabian, M., H. Allayee, J. Wong, W. Shi, X.P. Wang, Z. Shaposhnik, C.D. Funk, and A.J. Lusis. 2002. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91:120-126.
2. Funk, C.D. 2005. Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat. Rev. Drug Discov. 4:664-672.
3. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 220:568-575.
4. Samuelsson, B., S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176.
5. Reid, G.K., S. Kargman, P.J. Vickers, J.A. Mancini, C. Leveille, D. Ethier, D.K. Miller, J.W. Gillard, R.A. Dixon, and J.F. Evans. 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J. Biol. Chem. 265:19818-19823.
6. Soderberg-Naucler, C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259:219-246.
7. Soderberg-Naucler, C., K.N. Fish, and J.A. Nelson. 1997. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100:3154-3163.
8. Soderberg-Naucler, C., K.N. Fish, and J.A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 91:119-126.
9. Rakonjac, M., L. Fischer, P. Provost, O. Werz, D. Steinhilber, B. Samuelsson, and O. Radmark. 2006. Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc. Natl. Acad. Sci. USA. 103:13150-13155.
10. Janssen-Timmen, U., P.J. Vickers, U. Wittig, W.D. Lehmann, H.J. Stark, N.E. Fusenig, T. Rosenbach, O. Radmark, B. Samuelsson, and A.J. Habenicht. 1995. Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc. Natl. Acad. Sci. USA. 92:6966-6970.
11. Lammers, C.H., P. Schweitzer, P. Facchinetti, J.M. Arrang, S.G. Madamba, G.R. Siggins, and D. Piomelli. 1996. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J. Neurochem. 66:147-152.
12. Gupta, S., M. Srivastava, N. Ahmad, K. Sakamoto, D.G. Bostwick, and H. Mukhtar. 2001. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer. 91:737-743.
13. Wright, L., R.M. Tuder, J. Wang, C.D. Cool, R.A. Lepley, and N.F. Voelkel. 1998. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 157:219-229.
14. Zhang, Y.Y., J.L. Walker, A. Huang, J.F. Keaney, C.B. Clish, C.N. Serhan, and J. Loscalzo. 2002. Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem. J. 361:267-276.
15. Eriksson, E.E. 2004. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr. Opin. Lipidol. 15:553-558.
16. Aiello, R.J., P.A. Bourassa, S. Lindsey, W. Weng, A. Freeman, and H.J. Showell. 2002. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22:443-449.
17. Luster, A.D., and A.M. Tager. 2004. T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4:711-724.
18. Nieto, F.J., E. Adam, P. Sorlie, H. Farzadegan, J.L. Melnick, G.W. Comstock, and M. Szklo. 1996. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 94:922-927.
19. Hendrix, M.G., M.M. Salimans, C.P. van Boven, and C.A. Bruggeman. 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136:23-28.
20. Cottone, M., G. Pietrosi, G. Martorana, A. Casa, G. Pecoraro, L. Oliva, A. Orlando, M. Rosselli, A. Rizzo, and L. Pagliaro. 2001. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am. J. Gastroenterol. 96:773-775.
21. Roberts, W.H., J.M. Sneddon, J. Waldman, and R.E. Stephens. 1989. Cytomegalovirus infection of gastrointestinal endothelium demonstrated by simultaneous nucleic acid hybridization and immunohistochemistry. Arch. Pathol. Lab. Med. 113:461-464.
22. Koskinen, P., K. Lemstrom, C. Bruggeman, I. Lautenschlager, and P. Hayry. 1994. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am. J. Pathol. 144:41-50.
23. Li, F.L., G. Grauls, M. Yin, and C.A. Bruggeman. 1996. Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts. Transpl. Int. 9:S340-S344.
24. Lee, P.C., G.H. Gibbons, and V.J. Dzau. 1993. Cellular and molecular mechanisms of coronary artery restenosis. Coron. Artery Dis. 4:254-259.
25. Gosselin, J., P. Borgeat, and L. Flamand. 2005. Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation. J. Immunol. 174:1587-1593.
26. Flamand, L., P. Borgeat, R. Lalonde, and J. Gosselin. 2004. Release of anti-HIV mediators after administration of leukotriene B4 to humans. J. Infect. Dis. 189:2001-2009.
27. Genis, P., M. Jett, E.W. Bernton, T. Boyle, H.A. Gelbard, K. Dzenko, R.W. Keane, L. Resnick, Y. Mizrachi, D.J. Volsky, et al. 1992. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703-1718.
28. Qiu, H., A. Gabrielsen, H.E. Agardh, M. Wan, A. Wetterholm, C.H. Wong, U. Hedin, J. Swedenborg, G.K. Hansson, B. Samuelsson, et al. 2006. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. USA. 103:8161-8166.
29. Wentworth, B.B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258